Forbes

In this week’s edition of InnovationRx, we look at the spreading Ebola epidemic, the Midas list health investors, Lilly’s trio of vaccine deals, and more.

The Robert Wood Johnson Foundation is launching a campaign to ‘amplify the voices and experiences of people affected by high healthcare costs.”

GoodRx launched a new subscription allowing the uninsured and underinsured to access health services and prescription drugs at discounted rates.

Can you safely have brain and spine surgery in an ambulatory surgery center (ASC) and go home the same day? What does the research say? And what do the patients say?

Tim Cook’s leadership at Apple offers doctors a case study in what happens when money, mission and professional identity collide.

AI is being used by adults and youth for mental health, companionships, and romantic relationships. We review new data and recommendations from top organizations.

12-Yrs ago my Ebola piece was not about it arriving in the US. It was about an era where infectious disease could become a geopolitical & economic force. The era is now.

GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several different types of tumors including breast and lung

GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger co-payments to rise.

You may have seen the "climaxxing" trend on social media. Will this do anything to combat the so-called "sexual recession" in America, especially among Gen Zers?

Bill Cassidy’s Senate primary loss highlights the growing collision between public health and political survival — and offers lessons for America's leaders.